Crescent Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.About CBIO
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
CBIO Key Statistics
Stock Snapshot
With a market cap of 180.19M, Crescent Biopharma(CBIO) trades at $12.97. The stock has a price-to-earnings ratio of -0.37.
During the trading session on 2025-11-07, Crescent Biopharma(CBIO) shares reached a daily high of $13.20 and a low of $12.90. At a current price of $12.97, the stock is +0.5% higher than the low and still -1.7% under the high.
Trading volume for Crescent Biopharma(CBIO) stock has reached 42.42K, versus its average volume of 63.71K.
Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $44.77 and a low of $9.81.
Over the past 52 weeks, Crescent Biopharma(CBIO) stock has traded between a high of $44.77 and a low of $9.81.
CBIO News
Crescent Biopharma (CBIO) announced that preclinical data from CR-001, its PD-1 x VEGF bispecific antibody being developed for solid tumors, will be presented a...